EICHORPublic-registry site landscape for NCT06128369, “A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery”, a Inflammation Eye study sponsored by Oculis. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06128369 (registry record) |
| Study title | A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery |
| Official title | A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Ophthalmic Suspension in the Treatment of Inflammation and Pain Following Cataract Surgery |
| Sponsor | Oculis |
| Condition(s) | Inflammation Eye; Pain, Postoperative; Cataract |
| Phase | PHASE3 |
| Listed sites | 12 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT06128369.
Eichor generates a preliminary site-risk snapshot for NCT06128369 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
